Literature DB >> 6987484

Penbutolol in hypertension: evaluation of a new beta-adrenergic blocking drug.

J H Bett, R K Wilkinson, J Williams, H Ryan.   

Abstract

The hypotensive effect of penbutolol, a new beta-adrenergic blocking drug, has been evaluated in a doulbe-blind crossover trial on 15 patients. Blood pressures were significantly lower during active drug treatment (P less than 0.001), the average reduction being: 1.7/0.9 kPa (13/7 mmHg) erect.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987484

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  2 in total

1.  Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.

Authors:  L D Lameijer; L A Voermans; J J Houtzagers; D R Chadha
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

2.  Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.